Cite
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
MLA
Turner, Michael J., et al. “Reduction of Inflammation and Preservation of Neurological Function by Anti-CD52 Therapy in Murine Experimental Autoimmune Encephalomyelitis.” Journal of Neuroimmunology, vol. 285, Aug. 2015, pp. 4–12. EBSCOhost, https://doi.org/10.1016/j.jneuroim.2015.05.018.
APA
Turner, M. J., Pang, P. T., Chretien, N., Havari, E., LaMorte, M. J., Oliver, J., Pande, N., Masterjohn, E., Carter, K., Reczek, D., Brondyk, W., Roberts, B. L., Kaplan, J. M., & Siders, W. M. (2015). Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 285, 4–12. https://doi.org/10.1016/j.jneuroim.2015.05.018
Chicago
Turner, Michael J., Petti T. Pang, Nathalie Chretien, Evis Havari, Michael J. LaMorte, Julian Oliver, Nilesh Pande, et al. 2015. “Reduction of Inflammation and Preservation of Neurological Function by Anti-CD52 Therapy in Murine Experimental Autoimmune Encephalomyelitis.” Journal of Neuroimmunology 285 (August): 4–12. doi:10.1016/j.jneuroim.2015.05.018.